Welcome to WFIPP.org
For people living with incontinence and pelvic floor dysfunction.
The platform which is intended to act as a helpful resource for all stakeholders, patients, families, carers, HCPs and institutions who are in some way involved in the patient pathway relating to incontinence
BASEL, Switzerland, Nov. 16, 2023: Versameb AG (“Versameb”), a pre-clinical stage company focused on transforming RNA therapeutics to treat unmet medical needs, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application of VMB-100, a potency enhanced messenger ribonucleic acid (mRNA) encoding human insulin-like growth factor-1 (IGF […]Read more
If you struggle with bladder leaks during normal daily activities like coughing, sneezing, or during physical activity, you may be a candidate for Bulkamid.
Bulkamid is a minimally invasive and long-lasting treatment option for bladder leaks caused by Stress Urinary Incontinence (SUI).
When given the choice of treatment options for SUI, the majority of women choose Bulkamid.
The Commitment to Collaboration in Continence Care (4Cs) multistakeholder group met in Valencia on 10 November 2023. The meeting objectives were to: a) review progress made in 2023, and b) agree priorities for 2024, aligned with the 4Cs objectives. Discussion focused on maintaining momentum from the 1st EU Continence Health Summit “An Urge to Act”, which was held on 8 November in Brussels, Belgium.Read more
The European Institute for Women’s Health issued its 2024 EU Manifesto for Women’s Health! The document outlines the need for action on women’s health and provides key facts and figures on the current state of play for women in the EU. It describes the key priorities for improving the health and wellbeing of women across the […]Read more